# a Clinical Trial to Evaluate the Efficacy and Safety of Agnucaston Tablets in the Treatment of Premenstrual Syndrome (PMS)

> **NCT00672607** · PHASE2 · COMPLETED · sponsor: **Schwabe-Wenex International Ltd** · enrollment: 217 (actual)

## Conditions studied

- Premenstrual Syndrome

## Interventions

- **DRUG:** extracts of Vitex agnus castus tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00672607
- **Lead sponsor:** Schwabe-Wenex International Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2009-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00672607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00672607, "a Clinical Trial to Evaluate the Efficacy and Safety of Agnucaston Tablets in the Treatment of Premenstrual Syndrome (PMS)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00672607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*